BioNTech SE Net Foreign Exchange Gain
BioNTech SE (BNTX) reported Net Foreign Exchange Gain of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:NetForeignExchangeGain · last filed 2026-03-10
| Period end | Net Foreign Exchange Gain 12 month | Net Foreign Exchange Gain 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 15.50M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 65.00M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 66.20M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 0.00 EUR 20-F · filed 2023-03-27 | |
| 2019-12-31 | 2.30M EUR 20-F/A · filed 2022-10-26 | 2.34M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 6.05M EUR 20-F · filed 2021-03-30 |